Compositions and methods for enhancing immune tolerance
AssigneePresident and Fellows of Harvard College
InventorsDouglas A. Melton, Dario Gerace, Quan Zhou
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of producing a hypoimmune cell and methods of mediating localized immune tolerance.
Claims23
A hypoimmunogenic cell engineered to express one or more tolerogenic transgenes from one or more loci in the stem cell or progenitor cell which is not silenced during differentiation of the stem cell or progenitor cell to a desired differentiated cell type.
-16. (canceled)
A method of producing a hypoimmunogenic cell comprising engineering a stem cell or progenitor cell to express one or more tolerogenic transgenes from a locus in the stem cell or progenitor cell which is not silenced during differentiation of the cell to a desired cell type and exposing the stem cell or progenitor cell to conditions suitable for the stem cell or progenitor cell to differentiate to a desired cell type.
-32. (canceled)
A method of mediating localized immune tolerance comprising engineering a stem cell or progenitor cell to express one or more immunomodulatory agents from a locus in the stem cell or progenitor cell which is not silenced during differentiation of the cell to a desired cell type and exposing the stem cell or progenitor cell to conditions suitable for the stem cell or progenitor cell to differentiate to a desired cell type, thereby producing a desired cell type that secretes said one or more immunomodulatory agents.
-45. (canceled)
A cell engineered to express one or more immunomodulatory agents from one or more loci in a stem cell or progenitor cell which is not silenced during differentiation of the stem cell or progenitor cell to a desired differentiated cell type, wherein the one or more immunomodulatory agents is selected from the group consisting of IL-10, TGF-β and IL-2 or a modified IL-2.
(canceled)
(canceled)
Dependencies are inferred from the claim text.